Genesco Inc.

GCO · NYSE

$42.50▼ -0.51%

$0.22 today

Mkt cap $471.88M
P/E 23.0
Day $42.20 – $43.60

Confidence

High conviction

menu_book

The read

Genesco shares rally 9.5% post-Q1 2027 earnings despite unavailable EPS data

Genesco's stock surged 9.5% following Q1 2027 results with 3% revenue growth driven by Journeys' 5% comps and 21 new stores, offset by Schuh's 9% sales decline. EPS was not reported. Valuation remains attractive with forward P/E 27% below sector. Investors await June 3 earnings and guidance for growth clarity.

Confidence note: Analysis based on strong price reaction and detailed segment sales data; limited by unavailable EPS and explicit guidance.

fact_check

What happened

receipt_long

Earnings print

EPS data unavailable; consensus estimate was -2.55 for Q1 2027.

signpost

Guidance

No explicit guidance disclosed; market reaction suggests positive sentiment toward growth prospects.

candlestick_chart

Price reaction

Shares rose 9.48% on earnings day, closing at $42.72, reflecting strong investor enthusiasm.

newspaper

Street narrative

Revenue grew 3% led by Journeys' 5% comparable sales and 21 new stores; Schuh sales declined 9% due to fewer promotions. Operating margin and ROE remain weak at 1.1% and 3.7%, respectively. Institutional ownership is high at 88.9%, and valuation metrics indicate a discount to sector averages.

lightbulb

So what

swap_horiz

What changed

Stock price increased 9.5% after Q1 revenue growth of 3% despite missing EPS data.

sell

What the market is pricing

Market is pricing optimism on Journeys' growth and attractive valuation despite profitability concerns.

insights

Fundamental takeaway

Maintain a constructive bias; monitor upcoming guidance and margin trends for confirmation.

alt_route

Next 30–90 days

trending_upBull

40%

Sustained revenue growth and margin improvement drive EPS above consensus, lifting shares.

boltJune 3 earnings guidance confirms margin expansion
boltContinued comparable sales growth at Journeys

balanceBase

36%

Revenue growth continues modestly with stable margins; shares trade sideways to modestly higher.

boltGuidance aligns with current estimates
boltJourneys maintains steady comps

trending_downBear

24%

Profitability challenges persist with declining sales and weak margins, pressuring shares.

boltGuidance cut on revenue or margins
boltContinued Schuh sales decline

checklist

What to do

account_balance_wallet

If you hold it

Hold shares unless June 3 guidance signals margin contraction or sales weakness.

visibility

If you're watching

Add if post-earnings guidance confirms margin improvement and sustained sales growth; avoid if guidance is negative or EPS misses consensus.

radar

Keep on your radar

June 3 earnings and guidance release
Comparable sales trends at Journeys and Schuh brands
Operating margin and ROE changes in upcoming quarters
Institutional ownership shifts or insider activity